Obermatt

ETHZilla

NAQ:ETHZ · US68236V4014
BiotechnologyX-Small

360

32
Medium confidence — indicative
Profit price7
Owner Earnings Yield1
Dividend Yield1
Price/Sales67
EV / Gross Profit100
Price/Book74
Return on Capital10
Cash Return on Capital13
Return on Equity4
Profit margins49
Accruals100
Owner Earnings Margin7
Sales growth92
Profit growth61
Reinvestment14
Price momentum10
Debt load61
Refinancing84
Debt Payback1
Liquidity5
Analyst ratings22
Opinion Changes50
Price Target Upside9
Market mood6
Value Creation0/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

ETHZilla doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Based on 2/5 components.

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Employees1
ISINUS68236V4014
Last UpdateApr 2, 2026
Themes
Decentralized FinanceBlockchainFintechWeb3CryptocurrencyVirtual CurrencyBiopharmaBiotechnologyHealth CareLife ScienceTherapeutics

Description

Forum Markets, Incorporated, a technology company, operates in the decentralized finance (DeFi) industry. The company focuses on developing infrastructure that supports the origination, financing, and distribution of real-world assets (RWAs) through…

Analysis

Middle-of-the-road

Forum Markets, Incorporated is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is mixed and the balance sheet is adequate. The company scores 0/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
29
2026

All-time high

36

Mar 2026

All-time low

29

Jun 2026

Average rank

33

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
67
Price/Earnings
93
Price/Book
74
Dividend Yield
1
Value (overall)
82

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare ETHZilla with its peers
Research Solutions
NAQ:RSSS
88
CountryUSA
IndustryIT Services
SizeSmall
Full Stock Analysis →
Hyperliquid Strategies
NAQ:PURR
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Fennec Pharmaceuticals
NAQ:FENC
62
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
CSG Systems
NSQ:CSGS
28
CountryUSA
IndustryIT Services
SizeMedium
Full Stock Analysis →
Praxis Precision Medicines
NSQ:PRAX
37
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Immix Biopharma
NAQ:IMMX
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →